Mitsubishi Tanabe Pharma America, Inc.
Description
excerpt from site's contentText Size results Innovating Kidney Care Renal Newswire Mitsubishi Tanabe Pharma will receive and review grant funding requests for the following areas of therapeutic interest Uremic pruritus associated with hemodialysis Optimization of care for patients with renal disease Welcome Members of the kidney community peopl...
This is an automatically generated AboutUs page for mt-pharma-america.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- Chronic kidney disease
- CKD
- Renal disease
- Kidney disease
- Kidney
- Kidney function
- Kidney community
- Acute kidney failure
- Kidney care
- Renal care
- Nephrology
- Mitsubishi Tanabe Pharma America
- MTPA
- Mitsubishi Tanabe Pharma Corporation
- MTPC
- Mitsubishi Tanabe Pharma Development America
- MTDA
- Polycystic kidney disease
- Nephrocalcinosi
- Nephron
- Glomerulonephritis
- Glomerular filtration rate
- GFR
- Glomerular
- Creatinine
- Albumin
- Proteinuria
- Hyperphosphatemia
- Uremia
- Uremic Toxin
- Uremic toxin adsorbent
- Hyperparathyroidism
- Neurotrophin
- Neurotrophin enhancer
- DPP4 inhibitor
- Intracellular Ca handling modulator
- Myocardial infarction
- Diabetic neuropathy
- Diabetes mellitus
- PARP inhibitor
- Human serum albumin
- Human serum albumin recombinant
- Acute ischemic stroke
- Colestilan
- Teneligliptin
- Caldaret